The age and sex specific incidence rates for cerebral infarction, primary intracerebral haemorrhage and subarachnoid haemorrhage in a population of approximately 105,000 are presented. Over four years 675 patients with a first-ever stroke were registered with the Oxfordshire Community Stroke Project. The pathological diagnosis was confirmed by computerised tomography (CT) scan, necropsy or lumbar puncture (cases of subarachnoid haemorrhage only) in 78% ofcases and a further 17% were diagnosed according to the Guy's Hospital Stroke Diagnostic Score. The proportion of all first-ever strokes by pathological type was: cerebral infarction 81% (95% confidence interval 78-84), primary intracerebral haemorrhage 10% (8-12), subarachnoid haemorrhage 5% (3-7) and uncertain type 5% (3-7). These proportions are similar to other communitybased studies. The overall 30 day case fatality rate was 19% (16) (17) (18) (19) (20) (21) (22) , that for cerebral infarction being 10% (7-13), primary intracerebral haemorrhage 50% (38-62) and subarachnoid haemorrhage 46% (29-63). One year post stroke 23% (19) (20) (21) (22) (23) (24) (25) (26) (27) with cerebral infarction were dead and 65% (60-70) of survivors were functionally independent. The figures for primary intracerebral haemorrhage were 62% (43-81) dead and 68% (50-86) of survivors functionally independent and for subarachnoid haemorrhage were 48% (24-72) dead and 76% (56-96) of survivors functionally independent. There are important differences between these rates and those from other sources possibly due to more complete case ascertainment in our study. Nevertheless, the generally more optimistic early prognosis in our study, particularly for cases of cerebral infarction, has important implications for the planning of clinical trials and for the expected impact that any treatment might have on the general population.
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If our understanding and management of cerebrovascular disease in the community is to advance then pathologically homogeneous groups of patients need to be identified and studied.' Recently a number of large multicentre trials of acute stroke treatment and secondary stroke prevention have been undertaken and more are being planned. There is also increasing interest in hospital-based stroke data banks which can record the multiple physical examinations and detailed investigations which are only possible when patients are in hospital.2" Accurate population-based data about the incidence and outcome of the commonly diagnosed pathological types of stroke are needed to plan trials and to determine the relevance of the findings from hospital-based stroke data banks to the generality of patients with stroke. By using more detailed epidemiological data, trial designers may be able to predict which inclusion or exclusion criteria might lead to successful recruitment,4 whilst failure to do so will "virtually assure future therapeutic uncertainty".' The value of these types of data in the planning of a clinical trial of secondary stroke prevention in patients with non-valvular atrial fibrillation was reported recently. 5 Whilst community-based studies must provide information about the commonly diagnosed stroke types if they are to be of value, concern has been expressed about the accuracy of pathological diagnoses in such studies. 6 The Oxfordshire Community Stroke Project (OCSP) aimed to determine accurately the pathological type of first-ever stroke by CT and necropsy examination in an unbiased and representative sample of patients. 7 We present the incidence and outcome after one year for cerebral infarction (CI), primary intracerebral haemorrhage (PICH) and subarachnoid haemorrhage (SAH).
Methods
The methodology of the OCSP has been reported in detail previously.7 In summary, all patients in a population of approximately [3] [4] [5] [6] [7] "incident" event. The GHSDS was calculated for the remaining 145 (22%) patients. In 106 (16%) the score was less than 4, that is, there was a greater than 90% probability of the stroke being due to cerebral infarction, and in eight (1 %) it was greater than 25, that is, there was a greater than 90% probability of the stroke being due to intracranial haemorrhage. Even though it is widely available in developed countries, CT remains a hospitalbased facility and its use in community-based studies of cerebrovascular disease has been limited. Consequently, concern continues to be expressed about the accuracy of the pathological diagnoses in community studies6 and hence the interpretation of outcome data based on them. This would be of no consequence if patients admitted to hospital were always similar to those remaining at home but we have We cannot be quite as confident about the accuracy of the pathological diagnosis in patients classified using the GHSDS but this has been shown to be more accurate than an unstructured clinical diagnosis8 and should be sufficiently accurate for epidemiological if not clinical decision making purposes. Furthermore, by accepting only cases within the upper and lower 10% of the score it is likely that the predictive value is even greater than that for the overall score. We considered that more bias was likely to be introduced by categorising all such cases as "uncertain pathology" than by using the GHSDS. This view was supported by the finding of areas of low density typical of infarction within a single arterial territory (that is, they were unlikely to be the residua of PICH) on 19% of CT scans performed after 28 days from the onset of symptoms all of which had GHSDS scores less than 4 Subarachnoid haemorrhage E Not known rhage than ischaemia and, if so, this might account for the apparent decline in the incidence of haemorrhagic strokes in the most elderly group whilst the incidence of CI continued to rise steeply with age.
We emphasise that to be an incident case in our study a patient had to have had a first-ever in a lifetime stroke. This is particularly important when considering pathological types of stroke since the survival rates and therefore the proportion of patients who remain at risk of a recurrent stroke are so different. Harmsen and Wilhelmsen" reported a 30% higher CFR for recurrent strokes and Aho et al 33 noted a higher CFR among more disabled people which would have included those with residual deficits from previous strokes. Many trials will only include patients having their first clinically apparent stroke and therefore it is important to know the natural history of these patients. Figure 2 shows that the distribution of the pathological types of first stroke has been similar in the North American and European community-based studies. 22 retrospective casenote reviews and our data were collected prospectively, the Mayo Clinic record system is well established and validated and therefore it seems unlikely that this would account for all of the difference. A second possibility is that there has been a genuine decline in CFR over the last 20 years (since the mid-point of the Rochester study was 1962). In favour of this explanation would be the observation by Matsumoto et al22 that there was a trend towards increasing survival after CI over their study period. The fact that the overall 30 day CFR in the South Alabama study,26 which was performed at about the same time as the OCSP, was 22% also supports this hypothesis. However, our results do not support the hypothesis of Gross et al26 that the lower CFR in South Alabama compared with European studies (specifically Tilburg, Netherlands27) might be due to "modern aggressive medical and surgical management" since the OCSP patients have a similar CFR to those in South Alabama yet were managed in very conventional ways, over 40% of them entirely at home. A more likely explanation is that the rather high CFRs in Tilburg were for all strokes in the study period rather than just lifetime first-ever strokes. A further explanation might be that as part of the presumed overall declining incidence of stroke, 25 3638 there has been a disproportionately large drop in the incidence of fatal or severely disabling strokes, perhaps of cardio-embolic origin. At present, there is little detailed data concerning the incidence and outcome of subtypes of cerebral infarction though we will be publishing this in the future. 39 It is difficult to compare most outcome measures reported in the literature, especially for haemorrhagic stroke when the numbers are usually small. However, the most recent data on CI from Rochester report the outcome according to the original Rankin scale. 35 With this, 48% of survivors at one year were in some way dependent on others compared with only 35% in the OCSP. Again, this suggests that there might have been more complete detection ofmild cases in the OCSP or that there has been a decline in the incidence of severe ischaemic strokes. Whatever the reasons, there seem to be significantly more patients who might benefit from secondary preventive measures than might have been predicted from previous studies. Many of these, in the United Kingdom at least, are currently being managed purely by general practitioners. Whilst further epidemiological studies of stroke which are able to obtain a high proportion of definite pathological diagnoses would be of value, particularly if they are in different parts of the world, attention should now be given to delineating the epidemiology of homogeneous subgroups of the major pathological types of stroke.
Appendix DEFINITIONS OF PATHOLOGICAL TYPES OF STROKE
Definite cerebral infarction Cases of stroke (defined by clinical criteria described previously-paper 1) with: (a) CT performed on or before the 28th day from the onset of symptoms which shows an area of low attentuation in a region compatible with the clinical symptoms and signs, or (b) CT performed on or before the 28th day from the onset of symptoms which shows no abnormality in any region compatible with the clinical symptoms and signs, or (c) CT performed on or before the 28th day from the onset of symptoms which shows an area of irregular high attenuation within an area of low attentuation, considered to be due to haemorrhagic infarction by a consultant neuroradiologist, in a region compatible with the clinical symptoms and signs, or (d) An adequate necropsy examination which shows an area of cerebral infarction, either pale or haemorrhagic, in a region compatible with the clinical symptoms and signs.
Probable cerebral infarction Cases of stroke who do not have a CT scan on or before the 28th day of the onset of symptoms or an adequate necropsy examination, but in whom sufficient clinical details are available to derive the Guy's Hospital Stroke Diagnostic Score (GHSDS) and the score is less than 4 (that is, there is a greater than 90% chance that the stroke is due to cerebral infarction).
Definite primary intracerebral haemorrhage
Cases of stroke with: (a) A CT scan which shows an area of uniform high attentuation unrelated to tumour or trauma, in a region compatible with the clinical symptoms and signs, or (b) An adequate necropsy examination which shows an intracerebral haemorrhage of an age and in a region compatible with the clinical symptoms and signs.
Probable primary intracerebral haemorrhage Cases of stroke who do not have a CT scan on or before the 28th day from the onset of symptoms or a necropsy examination, but with sufficient clinical details to derive a GHSDS which must be greater than 24, that is, there is a greater than 90% chance that the stroke is due to intracranial haemorrhage.
Definite subarachnoid haemorrhage Cases with a typical history of acute onset of headache, meningism, photophobia, sometimes with loss of consciousness, not associated with trauma, with: (a) A CT scan which shows subarachnoid blood, In cases where subarachnoid and intracerebral haemorrhage coexist, the primary site of bleeding must be considered to be subarachnoid by a neuroradiologist or neuropathologist.
Probable subarachnoid haemorrhage Cases with the clinical features of subarachnoid haemorrhage but without confirmatory investigations.
Uncertain types Cases of stroke without adequate confirmatory investigations and in whom the GHSDS score is between 4 and 24 or for whom clinical details are insufficient to derive the score.
